Journey Medical Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Journey Medical stock have an average target of 10, with a low estimate of 9.00 and a high estimate of 11. The average target predicts an increase of 67.50% from the current stock price of 5.97.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$10	$11	$11
Change	+50.75%	+67.50%	+84.25%	+84.25%

* Price targets were last updated on Sep 6, 2024.

Analyst Ratings

The average analyst rating for Journey Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	4	4	4	4	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Thomas Flaten Lake Street	Lake Street	Strong Buy Initiates $9	Strong Buy	Initiates	$9	+50.75%	Sep 6, 2024
Jason Wittes Roth MKM	Roth MKM	Strong Buy Initiates $11	Strong Buy	Initiates	$11	+84.25%	Jun 28, 2024
Scott Henry Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $8.5	Strong Buy	Initiates	$8.5	+42.38%	Feb 16, 2024
Kalpit Patel B. Riley Securities	B. Riley Securities	Strong Buy Reiterates $6	Strong Buy	Reiterates	$6	+0.50%	Sep 7, 2023
Kalpit Patel B. Riley Securities	B. Riley Securities	Strong Buy Maintains $3 → $6	Strong Buy	Maintains	$3 → $6	+0.50%	Jul 12, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

57.86M

from 79.18M

-26.93%

from 79.18M

Revenue Next Year

78.97M

from 57.86M

36.49%

from 57.86M

EPS This Year

-1.02

from -0.21

EPS Next Year

-0.09

from -1.02

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	34.92M	44.53M	63.13M	73.67M	79.18M	57.86M	78.97M	112.43M
Revenue Growth	-	27.52%	41.78%	16.69%	7.48%	-26.93%	36.49%	42.37%
EPS	0.36	0.49	-4.32	-1.69	-0.21	-1.02	-0.09	0.90
EPS Growth	-	36.11%	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	6.65
No. Analysts	-	-	-	-	-	6	6	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	60.2M	86.8M	133.4M
Avg	57.9M	79.0M	112.4M
Low	54.7M	70.3M	91.6M

Revenue Growth

Revenue Growth	2024	2025	2026
High	-24.0%	50.1%	68.9%
Avg	-26.9%	36.5%	42.4%
Low	-31.0%	21.5%	15.9%

EPS Forecast

EPS	2024	2025	2026
High	-1.00	0.16	1.90
Avg	-1.02	-0.09	0.90
Low	-1.02	-0.60	-0.05

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.